Glioma-derived versican promotes tumor expansion via gliomaassociated microglial/macrophages Toll-like receptor 2 signaling.

MLA

Hu, Feng, et al. “Glioma-Derived Versican Promotes Tumor Expansion via Gliomaassociated Microglial/Macrophages Toll-like Receptor 2 Signaling.” Neuro-Oncology, vol. 17, no. 2, Feb. 2015, pp. 200–10. EBSCOhost, https://doi.org/10.1093/neuonc/nou324.

APA

Hu, F., Dildar a Dzaye, O., Hahn, A., Yu, Y., Joey Scavetta, R., Dittmar, G., Kaczmarek, A. K., Dunning, K. R., Ricciardelli, C., Rinnenthal, J. L., Heppner, F. L., Lehnardt, S., Synowitz, M., Wolf, S. A., & Kettenmann, H. (2015). Glioma-derived versican promotes tumor expansion via gliomaassociated microglial/macrophages Toll-like receptor 2 signaling. Neuro-Oncology, 17(2), 200–210. https://doi.org/10.1093/neuonc/nou324

Chicago

Hu, Feng, Omar Dildar a Dzaye, Alexander Hahn, Yong Yu, Rick Joey Scavetta, Gunnar Dittmar, Adrian Kamil Kaczmarek, et al. 2015. “Glioma-Derived Versican Promotes Tumor Expansion via Gliomaassociated Microglial/Macrophages Toll-like Receptor 2 Signaling.” Neuro-Oncology 17 (2): 200–210. doi:10.1093/neuonc/nou324.